All Deals
March 13, 2026 - Deals
Ripple Valued At $50 Billion Following $750 Million Buyback From Investors And Employees
Ripple is valued at about $50 billion after planning a $750 million share buyback from investors and employees, according to a report by Bloomberg. The fintech, known for its ties to the XRP cryptocurrency, has seen its valuation climb roughly 25% since raising $500 million in November from investors including affiliates of Citadel Securities and Fortress Investment Group, standing out as a rare growth story in a crypto market that has slumped even as the company expands through acquisitions and global payments infrastructure.
FOUNDERS: Ryan Fugger, Chris Larsen, Jed McCaleb & Arthur Britto
VALUATION: $50,000,000,000
HQ: San Francisco, California
#VentureCapital #Ripple #TradedVC
More Deals
View AllColossal Biosciences In Talks For Funding Round Targeting $23 Billion ValuationColossal Biosciences, the de-extinction biotech startup known for its efforts to recreate the woolly mammoth and other extinct species, is reportedly in talks to raise new funding at a valuation of roughly $23 billion–$24 billion, according to Axios. The potential raise would mark a significant jump for the five-year-old company, with investors valuing not only its genetic-engineering programs but also its broader genomics, reproductive technology, conservation, and intellectual property platform. Colossal has begun generating revenue through conservation technology sales and technology spinouts, including Astromech, an AI-driven predictive modeling company, and Form Bio, a computational biology platform, expanding its value beyond de-extinction efforts.
FOUNDERS: Ben Lamm & George Church
TARGET VALUATION: $23,000,000,000
HQ: Dallas, Texas
#VentureCapital #ColossalBiosciences #BenLamm #GeorgeChurch #TradedVC